Share

Big pharma on a buying spree as Celgene buys Juno and Sanofi buys Bioverativ

The "Squawk on the Street" crew discusses Celgene's $9 billion cash deal for Juno Therapeutics and Sanofi's $11.6 billion bid for Massachusetts-based Bioverativ.
03:06
Mon, Jan 22 20189:08 AM EST